Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine
- PMID: 954239
Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine
Abstract
Hemosiderosis following regular administration of parenteral iron was observed in a patient receiving maintenance hemodialysis. Infusions of desferrioxamine in doses of 2,3 and 4 g each resulted in the removal of approximately 45 mg of iron during dialysis. Desferrioxamine 2 g was infused thrice weekly during dialysis for twelve months. Body iron stores, as judged by liver iron and serum ferritin concentrations, fell by about half. This agrees well with the result calculated from the amount of iron administered and the amount removed during dialysis.
Similar articles
-
[Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].Nephrologie. 1981;2(4):165-70. Nephrologie. 1981. PMID: 7329501 French.
-
Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis.Q J Med. 1987 Dec;65(248):1015-24. Q J Med. 1987. PMID: 3455553
-
Iron removal by desferrioxamine in patients on chronic hemodialysis--kinetic study and long-term results.Contrib Nephrol. 1985;49:44-55. Contrib Nephrol. 1985. PMID: 3830570
-
[Current possibilities in the therapy of iron overload].Vnitr Lek. 1994 Sep;40(9):605-8. Vnitr Lek. 1994. PMID: 7975366 Review. Czech.
-
Iron metabolism and chelation therapy in hemosiderosis.Curr Top Hematol. 1978;1:127-50. Curr Top Hematol. 1978. PMID: 400529 Review. No abstract available.
Cited by
-
Morphological changes of the liver in uremic patients treated with chronic hemodialysis--laparoscopic observations and light- and electron-microscopic studies.Gastroenterol Jpn. 1980;15(3):212-20. doi: 10.1007/BF02774270. Gastroenterol Jpn. 1980. PMID: 7399221
-
Continuous IV Deferoxamine for Chronic Iron Overload in Patients Undergoing Hemodialysis by Home Parenteral Therapy: A Case Report and Literature Review.Can J Hosp Pharm. 2024 Oct 9;77(4):e3577. doi: 10.4212/cjhp.3577. eCollection 2024. Can J Hosp Pharm. 2024. PMID: 39386972 Free PMC article. No abstract available.
-
Diagnosis and treatment of iron overload in paediatric patients on chronic haemodialysis.Pediatr Nephrol. 1988 Jul;2(3):303-8. doi: 10.1007/BF00858682. Pediatr Nephrol. 1988. PMID: 3153030
-
Hepatic hemosiderosis in maintenance hemodialysis (MHD) patients.Dig Dis Sci. 1980 May;25(5):363-8. doi: 10.1007/BF01308060. Dig Dis Sci. 1980. PMID: 7371474 No abstract available.
-
Treatment of iron overload in children and adolescents on chronic haemodialysis.Eur J Pediatr. 1990 Feb;149(5):359-62. doi: 10.1007/BF02171568. Eur J Pediatr. 1990. PMID: 2311634